Blog

Dr. Yi Lin discusses the future of CART therapy at EHA2024

Photo from Abner Antonio Murray/X

Jun 22, 2024, 12:17

Dr. Yi Lin discusses the future of CART therapy at EHA2024

Abner Antonio Murray, Oncology Fellow at UNC School of Medicine, shared a post on X:

“Exciting insights from EHA2024! Dr. Yi Lin discusses the future of CART therapy, highlighting the feasibility of outpatient treatments in Lymsm! Points:

Remote patient monitoring enhances safety.
Outpatient criteria: Decreased tumor bulk, early referral, ECOG PS 0, low inflammatory state, and caregiver compliance.
Caution with older patients with reduced capacity, cardio/renal/lung complications, CNS involvement, autoimmune/neuro conditions, and inadequate caregiver support.”

Source: Abner Antonio Murray/X

Abner Antonio Murray cancer cardio/renal/lung complications CART therapy CNS ECOG PS EHA2024 inadequate caregiver support Lymsm OncoDaily Oncology Outpatient criteria outpatient treatments Remote patient monitoring Yi Lin

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage